Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution.
Gossmann, Jan
Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution. [electronic resource] - Clinical transplantation - 431-4 p. digital
Publication Type: Case Reports; Journal Article
1399-0012
10.1111/j.1399-0012.2008.00936.x doi
Adult
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Murine-Derived
Glomerulosclerosis, Focal Segmental--drug therapy
Hepatitis B
Humans
Immunologic Factors--adverse effects
Kidney Transplantation
Male
Recurrence
Reoperation
Rituximab
Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution. [electronic resource] - Clinical transplantation - 431-4 p. digital
Publication Type: Case Reports; Journal Article
1399-0012
10.1111/j.1399-0012.2008.00936.x doi
Adult
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Murine-Derived
Glomerulosclerosis, Focal Segmental--drug therapy
Hepatitis B
Humans
Immunologic Factors--adverse effects
Kidney Transplantation
Male
Recurrence
Reoperation
Rituximab